Should prophylactic antibiotics be used in afebrile neutropenic oncology patients? Commentary

Nature Clinical Practice Oncology

Volumn 3, Issue 3, 2006, Pages 130-131

  Hughes, Walter T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Bacteremia; Fever; Infections; Neutropenia; Prophylactic antibiotics

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CANCER PATIENT; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; FEBRILE NEUTROPENIA; GRAM NEGATIVE SEPSIS; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; INFECTION RATE; META ANALYSIS; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMATIC REVIEW;

EID: 33645378509     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0431     Document Type: Short Survey

References (7)

1. Bodey GP et al. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340
2. Castagnola E et al. (2005) Bloodstream infections and invasive mycoses in children undergoing treatment for acute leukemia: A 13-year experience at a single institution. Eur J Cancer 41: 1439-1445
3. Robinson JL and Rennie RP (2002) Outcome of bacteremia and fungernia in paediatric oncology patients. Can J Infect Dis Microbiol 13: 375-381
4. Gray JW (2004) A 7-year study of bloodstream infections in an English children's hospital. Eur J Pediatr 163: 530-535
5. Cullen M et al. (2005) Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353: 988-998
6. Bucaneve G et al. (2005) Levofloxacin to prevent bacterial infections in patients with cancer and neutropenia. N Engl J Med 353: 977-987
7. Gafter-Gvili A et al. (2005) Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142: 979-995